Decheng Capital Global Healthcare Fund (Master), LP
SEC CIK 1949026 · EDGAR
BoughtSold
Most active insiders at BYSI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Decheng Capital Global Healthcare GP, LLC | 10% | — | $283.9K |
| 2 | Decheng Capital China Life Sciences USD Fund II, L.P. | 10% | — | $227.7K |
| 3 | Decheng Capital Management III (Cayman), LLC | 10% | — | $39.0K |
| 4 | Cui Xiangmin | 10% | — | $13.8K |
| 5 | Huang Lan | CEO, Dir, 10% | — | — |
Decheng Capital Global Healthcare Fund (Master), LP made no open-market trades at BYSI in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-09-16 | 2025-09-12+ | BYSI | BeyondSpring Inc. | Decheng Capital Global Healthcare Fund (Master), LP | 10% | S - Sale | $1.85 | -4,110 | 1.87M | -0.2% | -$7,603 |
| MI | 2025-08-25 | 2025-08-21+ | BYSI | BeyondSpring Inc. | Decheng Capital Global Healthcare Fund (Master), LP | 10% | S - Sale | $1.77 | -5,710 | 1.92M | -0.3% | -$10.1K |
| D | 2024-01-31 | 2024-01-29 | CGON | CG Oncology, Inc. | Decheng Capital Global Healthcare Fund (Master), LP | 10% | C - Cnv Deriv | — | +3.63M | 4.56M | +390% | — |
| DI | 2024-01-31 | 2024-01-29 | CGON | CG Oncology, Inc. | Decheng Capital Global Healthcare Fund (Master), LP | 10% | P - Purchase | $19.00 | +400.0K | 400.0K | New | +$7.60M |
Purchase Sale Sale after option exercise All abbreviations